Incisional Negative Pressure Wound Therapy for Prevention of Postoperative Infections Following Caesarean Section

NCT01890720 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 876

Last updated 2017-01-31

No results posted yet for this study

Summary

The purpose of this study is to examine whether obese women (BMI \>= 30) who give birth by caesarean section have a reduced incidence of wound infection and dehiscence when incisional Negative Pressure Wound Therapy is applied prophylactically following caesarean section.

Conditions

  • Surgical Wound Infection
  • Infection; Cesarean Section
  • Cesarean Section; Dehiscence
  • Complications; Cesarean Section
  • Complications; Cesarean Section, Wound, Dehiscence
  • Wound; Rupture, Surgery, Cesarean Section

Interventions

DEVICE

iNPWT

The Incisional Negative Pressure Wound Therapy (iNPWT) will be applied over the clean closed incision immediately following the operation (caesarean section). In the intervention group the therapy will be left in situ for five days.

OTHER

Standard postoperative wound dressing

A standard wound dressing will be applied over the clean closed incision immediately following the operation (caesarean section). In the control group the dressing will be left in situ for at least 24 hours as standard procedure.

Sponsors & Collaborators

  • Region of Southern Denmark

    collaborator OTHER
  • University of Southern Denmark

    collaborator OTHER
  • Hvidovre University Hospital

    collaborator OTHER
  • Smith & Nephew, Inc.

    collaborator INDUSTRY
  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Nana Hyldig, PhD Student · Odense University Hospital, department of Plastic Surgery, University of Southern Denmark, Faculty of Health Sciences, institute of Clinical Research, research unit, department of Gynaecology and Obstetrics

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-10
Primary Completion
2016-10-13
Completion
2016-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01890720 on ClinicalTrials.gov